Unitedhealth Group Inc header image

Unitedhealth Group Inc

UNH

Equity

ISIN null / Valor 1078451

New York Stock Exchange, Inc (2026-06-26)
USD 427.89+2.97%

Unitedhealth Group Inc
UMushroom community rating:

star star star star star
3.51 68 votes No rating yet
NegativeNeutralPositive

About company

UnitedHealth Group Inc. is a diversified health care company, operating through its two main subsidiaries, Optum and UnitedHealthcare, to foster a modern, efficient health system. Optum focuses on improving health care delivery through technology and data, providing tools and support to enhance the health of individuals and communities. UnitedHealthcare, on the other hand, offers a comprehensive range of health benefits, including affordable coverage and access to quality care, aimed at simplifying the health care experience for consumers. UnitedHealth Group is committed to serving the health care needs of over 152 million people worldwide, promoting a value-based care system that emphasizes compassionate and equitable treatment. The company's efforts are geared towards making high-quality care both affordable and accessible, leveraging cross-sector collaboration and technological innovation to meet consumer needs and improve the overall health care landscape.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

41.4%1Y
-10.7%3Y
5.66%5Y

Performance

41.0%1Y
38.2%3Y
32.9%5Y

Volatility

Market cap

388586 M

Market cap (USD)

Daily traded volume (Shares)

10,588,248

Daily traded volume (Shares)

1 day high/low

509.71 / 500.7

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.51

68 votes
Performance:
starstarstarstarstar
3.29
Innovation:
starstarstarstarstar
3.17
Society:
starstarstarstarstar
3.40
Nature:
starstarstarstarstar
3.29
Aleenah Moghal
United Kingdom, 21 Feb 2026
star star star star star
undervalued, in the long term this will generate impressive returns, UNH is a premier company in the managed healthcare sector. The recent, steep decline caused by regulatory fears (Medicare Advantage) has improved its long term valuation, but in short term volatility is expected to continue.
Harry Root
United Kingdom, 21 Feb 2026
star star star star star
Undervalued in recent times
George Williams
United Kingdom, 20 Feb 2026
star star star star star
High Quality Undervalued

EQUITIES OF THE SAME SECTOR

FibroGen Inc
FibroGen Inc FibroGen Inc Valor: 25953994
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.32%USD 7.24
Pacira BioSciences Inc
Pacira BioSciences Inc Pacira BioSciences Inc Valor: 12338490
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.57%USD 25.24
M1 Kliniken AG
M1 Kliniken AG M1 Kliniken AG Valor: 29694419
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.94%EUR 18.90
Limes Schlosskliniken AG
Limes Schlosskliniken AG Limes Schlosskliniken AG Valor: 38625581
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.93%EUR 545.00
AbbVie Inc
AbbVie Inc AbbVie Inc Valor: 20145667
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.20%USD 253.35
NATCO Pharma Limited
NATCO Pharma Limited NATCO Pharma Limited Valor: 30461955
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%INR 903.45
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals Inc Catalyst Pharmaceuticals Inc Valor: 2649177
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.25%USD 31.50
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.61%USD 291.37
Ligand Pharmaceuticals Inc
Ligand Pharmaceuticals Inc Ligand Pharmaceuticals Inc Valor: 12015449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.59%USD 303.59
Boston Scientific Corp
Boston Scientific Corp Boston Scientific Corp Valor: 913577
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.07%USD 44.23